The American Academy of Pediatrics endorsed guidelines in 2015 for the evaluation, diagnosis, and management of congenital muscular dystrophy. The guidelines were published in Neurology and aimed to provide evidence-based clinical recommendations. The endorsement automatically expires after 5 years unless reaffirmed or revised by that time.